From QIBA Wiki
Revision as of 15:13, 17 June 2022 by Jlisiecki (talk | contribs) (→‎FDA Guidance)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

QIBA in the Literature Citations

RSNA staff maintains a QIBA citation library in EndNote. Scientific journals featuring QIBA projects or articles that may reference QIBA and its efforts are included.

Articles are divided into three categories:

  • Generated by QIBA research teams
  • References QIBA
  • Metrology Publications


All QIBA leaders have been automatically provided access to the collections and anyone else will be given access upon request. If you already have an EndNote account: please log in to view the collections. All three QIBA citation groups should appear under, “Groups Shared by Others.”

If you do not already have an EndNote account: you can register for the free, web-based version called EndNote Basic. If additional assistance is needed in gaining access to the collections please send an email to: QIBA staff.

U.S. Food and Drug Administration (FDA) Guidance

The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions Guidance for Industry and Food and Drug Administration Staff was released on June 16, 2022, and can be accessed at this link or via the PDF below:

This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.

QIBA Historical Initiative

Cancer Moonshot.jpg

Cancer Moonshot & QIBA [1]

  • RSNA/QIBA is very pleased to announce that two of the QIBA Profiles relevant to cancer patients have been referenced and supported by the Federal Cancer Moonshot Initiative ( as ways to advance research and outcomes.
  • The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date. Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.

Biomarker Status Update Posters

QIBA Posters from RSNA Annual Meetings Archive

QIBA Special Interest Sessions at the RSNA Scientific Assembly and Annual Meeting







Google Chrome or Firefox browsers are recommended for viewing these PowerPoint presentations.





Consider also organizing or tagging presentations by topic?